✦ LIBER ✦

Studies on parameters predictive of the clinical effects of OK-432 in patients with malignant ascites

✍ Scribed by Takeshi Yoshida; Nakao Ishida

Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 90 KB
Volume: 13
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(91)90329-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical studies on cell-mediated immuni

Clinical studies on cell-mediated immunity in patients with malignant disease I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro

✍ Atsushi Uchida; Takashi Hoshino 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 713 KB

Immunopharmacological effects of OK-432

Immunopharmacological effects of OK-432 in patients with cancer. II. Effects of systematic administration on the kinetics of cytotoxicity

✍ T. Hoshino; S. Fujieda; S. Ameshima; H. Kitagawa; K. Iwamoto; Y. Kobayashi; K. A 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Immunopharmacological effects of OK-432

Immunopharmacological effects of OK-432 in patients with cancer. I. Effect of in vitro stimulation on the cytotoxic activity of immunocytes

✍ Takashi Hoshino; Sumiko Iho; Fumiaki Kura; Atsushi Uchida 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Humoral response to catumaxomab correlat

Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites

✍ Marion G. Ott; Frederik Marmé; Gerhard Moldenhauer; Horst Lindhofer; Michael Hen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 893 KB

The trifunctional antibody catumaxomab is a targeted immunotherapy for the intraperitoneal treatment of malignant ascites. In a Phase II/III trial in cancer patients (__n__ = 258) with malignant ascites, catumaxomab showed a clear clinical benefit __vs__. paracentesis and had an acceptable safety pr

Randomized clinical study of the efficac

Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites

✍ Paolo Angeli; Manuela Dalla Pria; Erica de Bei; Grazia Albino; Lorenza Caregaro; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 704 KB

The effect of peritoneovenous shunting o

The effect of peritoneovenous shunting on catecholamine metabolism in patients with hepatic ascites

✍ Professor Laurence M. Blendis; Michael J. Sole; Peter Campbell; Alan G. Lossing; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

The elevated catecholamine levels in cirrhotic patienta with ascites have been propaeed to be due to sympathetic overactivity secondary either to reduced intraveocular volume or to an underlying cardiovascular abnormality such as reduced pressor responsiveness. Furthermore, these elevated catecholam